MARK A SR PRYGOCKI

CIK 1257544 · President · last filed 2026-06-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$18.86M

Companies

4

Total Filings

42

Lifetime Open-Market Net

-$5.67M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VRCA Director $5.73 $0 10 2026-06-09
Clarus Therapeutics Holdings, Inc. (CRXTW) Delisted Director 5,766 $0.01 $78 $0 2 2022-06-09
Revance Therapeutics, Inc. (RVNC) Delisted Director $3.65 $0 2 2016-05-09
MRX President 304,453 $61.96 $18.86M -$5.67M 27 2012-04-05

Recent Filings · Page 3 of 5

42 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2011-05-18 MRX Mixed -$663.1K EDGAR
2011-04-06 MRX Tax (F) −3,529 -$117.1K EDGAR
2011-03-08 MRX Tax (F) −2,413 -$74.2K EDGAR
2011-03-03 MRX Mixed +45,791 -$65.4K EDGAR
2011-03-01 MRX Tax (F) −3,916 -$101.1K EDGAR
2011-02-09 MRX Tax (F) −758 -$21.0K EDGAR
2010-08-16 MRX Mixed −43,457 -$1.71M EDGAR
2010-07-23 MRX Tax (F) −893 -$22.0K EDGAR
2010-04-06 MRX Tax (F) −1,850 -$46.3K EDGAR
2010-03-09 MRX Tax (F) −1,607 -$37.1K EDGAR
Showing 2130 of 42
Page 3 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.